Outcome
    Moderate Evidence
    Effectiveness 3/5

    Saffron for Depression Symptom Reduction

    Saffron performs comparably to low-dose SSRIs for mild-to-moderate depression across several randomised trials.

    Overview

    Measured as a change in depression rating scores, saffron performs well for a botanical. Pooled randomised trials show standardised extract lowering symptom scores meaningfully more than placebo in mild to moderate depression, with effects appearing by six to eight weeks. The number to keep in mind is 30 mg per day. Almost the entire evidence base rests on that dose, and the trials behind it are small, short and drawn from a narrow set of research groups.

    What the evidence supports

    A statistically and clinically meaningful drop in depression rating scores at 30 mg/day over six to eight weeks.

    How It Works

    Crocin and safranal inhibit reuptake of serotonin, dopamine and noradrenaline in preclinical models, and both compounds reduce oxidative and inflammatory stress in neural tissue. Either pathway could plausibly move symptom scores.
    Because the proposed action overlaps with prescription antidepressants, saffron should be treated as pharmacologically active rather than as a benign food ingredient when other medications are involved.

    Dosing & Protocol

    Use the studied dose and give it a full course. Splitting the dose across the day is what most protocols specified, and taking it with food reduces nausea.

    Track it properly

    Score symptoms at baseline and again at eight weeks. Mood is too variable to judge from memory.

    Evidence

    Both linked meta-analyses pool randomised placebo-controlled trials and report significant reductions in depression scores with saffron extract.

    The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis

    Score: 6/10
    2019
    meta_analysis
    0

    Toth B, Hegyi P, Lantos T +11 more

    Saffron reduced depressive symptoms compared with placebo and was non-inferior to conventional antidepressants in mild to moderate depression.

    View source

    Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials

    Score: 6/10
    2013
    meta_analysis
    0

    Hausenblas HA, Saha D, Dubyak PJ +1 more

    Saffron supplementation significantly reduced depression symptom scores versus placebo and performed comparably to standard antidepressants.

    View source
    Consistency across two independent pooled analyses is reassuring; the shared pool of small source trials is not. Larger, geographically diverse replication is the missing piece.

    Safety

    At the studied dose, side effects are mild and uncommon: nausea, appetite change, headache, dry mouth. High doses are toxic, and saffron should be avoided in pregnancy because of its uterine-stimulant reputation.

    Do not self-manage severe depression

    Severe symptoms, or any thoughts of self-harm, need urgent professional care rather than a supplement trial.

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    —Combine only under medical supervision
    —Tell the prescriber before combining
    —Monitor if readings run low

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.